Background Total mesorectal excision is the gold standard treatment of mid-and low-lying
rectal cancer. Lateral pelvic lymph node dissection has been suggested as an approach to …

Colorectal cancer is the third most common and the second deadliest cancer worldwide. To
date, colorectal cancer becomes one of the most important challenges of the health system …

Background: Neoadjuvant concurrent chemoradiotherapy (nCCRT) followed by total
mesorectal excision has become the standard of care for advanced rectal cancer, but the …

The incidence of melanoma is increasing and prolonged exposure to ultraviolet (UV)
radiation remains the main risk factor. Public health measures have been vital in tackling the …

Background Rectal cancers represent 35% of colorectal cancers; 90% are
adenocarcinomas, while squamous cell carcinoma accounts for 0.3% of them. Given its …

Background: Neoadjuvant therapy (NT) is increasingly used for patients with localized
gastrointestinal (GI) cancers. There is little data assessing patient experience and quality of …

BACKGROUND Mixed tumors of the colon and rectum, composed of a combination of
epithelial and endocrine elements of benign and malignant potential are rare neoplasms …

Complete tumor response can be achieved in a certain proportion of patients with locally
advanced rectal cancer, who achieve maximal response to neoadjuvant therapy (NAT). For …

Colorectal cancer is the third most malignant gastrointestinal tumor. Although traditional
chemotherapy and radiotherapy have been widely used for colorectal cancer, the treatment …

Simple Summary We present the early results of a novel partial bulky-tumor irradiation using
carbon ions and protons. This approach explores the radiation-induced bystander and …